Preexposure Prophylaxis Initiation and Retention in Care Over 5 Years, 2012-2017: Are Quarterly Visits Too Much?

Clin Infect Dis. 2018 Jul 2;67(2):283-287. doi: 10.1093/cid/ciy160.

Abstract

Retention in preexposure prophylaxis (PrEP) care is critical to elimination of human immunodeficiency virus. We reviewed all Howard Brown Health patients receiving PrEP (n = 5583) from 2012 to 2017. Among those with 12 months of follow-up, 43% remained in care, yet only 15% had all 4 quarters with a PrEP visit. Insurance status and comorbid conditions were drivers of retention in care.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Comorbidity
  • Female
  • HIV Infections / prevention & control*
  • Homosexuality, Male
  • Humans
  • Insurance, Health
  • Male
  • Middle Aged
  • Pre-Exposure Prophylaxis*
  • Retention in Care / standards*
  • Young Adult

Substances

  • Anti-HIV Agents